Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Vistagen Therapeutics is a late-stage biopharmaceutical company focused on developing intranasal neurocircuitry-based therapies for mental health and neurological disorders. Its pipeline includes product candidates targeting social anxiety, depression, menopausal symptoms, mental fatigue, and cancer cachexia, utilizing non-systemic pherines with rapid-onset effects. The company aims to address unmet medical needs with innovative, safe, and targeted treatments for prevalent conditions.
This description was generated via AI from an annual report. Updated about 1 year ago.